DrayA.The physiology and pharmacology of mammalian basal ganglia. Progress in Neurobiology1980; 14: 221–335.
2.
KebabianJW, CalneDB. Multiple receptors for dopamine. Nature1979; 277: 93–96.
3.
LeeT, SeemanP, RajputA, FarleyIJ, HornykiewiczO.Receptor basis for dopaminergic supersensitivity in Parkinson's disease. Nature1978; 273: 897–900.
4.
HoehnMM, YahrMD. Parkinsonism: Onset, progression and mortality. Neurology1967; 17: 427–442.
5.
LesserRP, FahnS, SniderSR, CoteLJ, IsgreenWP, BarrettRE. Analysis of the clinical problems in Parkinsonism and the complicatioons of longterm levodopa therapy. Neurology1979; 29: 1253–1260.
6.
HardieRJ, LeesAJ, SternGM. The controversial role of bromocriptine in Parkinson's disease. Clinical Neuropharmacology1985; 2: 150–155.
7.
LeesAJ, SternGM. Sustained bromocriptine therapy in previously untreated patients with Parkinson's disease. J Neurol Neurosurg and Psychiat1981; 44: 1020–1023.
